SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
June 29, 2004
Uroplasty, Inc.
Minnesota | 000-20989 | 41-1719250 | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File No.) | (IRS Employer Identification No.) |
2718 Summer Street N.E.
Minneapolis, Minnesota 55413-2820
(612) 378-1180
N/A
Item 5. Other Events and Regulation FD Disclosure. | ||||||||
Item 7. Financial Statements, Pro Forma Financial Statements and Exhibits | ||||||||
SIGNATURES | ||||||||
Press Release |
Item 5. Other Events and Regulation FD Disclosure.
Uroplasty has filed an extension of time to file its annual report on Form 10-KSB that would otherwise be due today. The Company is preparing disclosure for a financial restatement related to the accounting for its Dutch subsidiarys pension plan. A copy of the Companys press release is attached as an exhibit.
Item 7. Financial Statements, Pro Forma Financial Statements and Exhibits
(a) | Not applicable. | |||
(b) | Not applicable. | |||
(c) | Exhibits. |
99.1
|
Press Release dated June 29, 2004. |
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: June 29, 2004
UROPLASTY, INC. |
||||
By | /s/ Daniel G. Holman | |||
Daniel G. Holman, President and | ||||
Chief Executive Officer | ||||
-3-